Back to search

Article

An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defense

2023-11-16

Abstract excerpt

<h4>ABSTRACT</h4> The prevalence of multidrug resistant (MDR) bacterial infections continues to rise as the development of antibiotics needed to combat these infections remains stagnant. MDR enterococci are a major contributor to this crisis. A potential therapeutic approach for combating MDR enterococci is bacteriophage (phage) therapy, which uses lytic viruses to infect and kill pathogenic bacteria. While phage...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
040714b1-1eb2-5a44-8633-416929905f51
DOI
10.1101/2023.11.16.567456
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defenseDOI 10.1101/2023.11.16.567456
Select a neighboring publication to make it the new centre.